Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing

Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia

Avid Bioservices Receives Five 2020 CMO Leadership Awards

Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020

Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer

Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019